Experimental evaluation reveals Citrus hystrix essential oil reduces pain and inflammation in mice, indicating its therapeutic potential.
Citrus hystrix DC. peel essential oil, rich in bioactive compounds, is traditionally used for pain, fever, and inflammation. This study evaluated its dose-dependent effects in mice following oral administration at 50, 100, and 150 mg/kg. The negative control group received distilled water, while positive controls included tramadol (5 mg/kg, p.o.) for analgesia, paracetamol (150 mg/kg, p.o.) for antipyresis, and indomethacin (10 mg/kg, p.o.) for inflammation. Analgesic activity was assessed via hot plate and tail-flick tests at 30, 60, and 90 minutes post-treatment. EOCHP150 significantly increased latency time in the hot plate test (p < 0.01) and achieved 72.5% inhibition in the tail-flick test. Yeast-induced pyrexia (20% Brewer’s yeast, 10 mL/kg, s.c.) was used to assess antipyretic activity, with EOCHP150 reducing rectal temperature by 4.0% at 4 hours, comparable to paracetamol. Carrageenan-induced paw edema (1% carrageenan, 50 µL, s.c.) showed a 46% inhibition in paw swelling at 4 hours with EOCHP150, accompanied by significant suppression of COX-2, PGE2, TNF-α, IL-1β, and IL-6 levels (p < 0.01). Strong correlations were observed between EOCHP dose and pharmacodynamic responses. These findings support EOCHP as a promising multi-target natural agent for the management of pain, fever, and inflammation.
No takes yet. Share an insight, caveat, or question.
Nhung et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: